Aspirine and/or low-molecular weight heparin for women with unexplained recurrent miscarriages and/or intra-uterine fetal death.

Recruiting

• Registration Number: NL-OMON26868

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Women with at least 2 unexplained miscarriages and/or intra-uterine fetal deaths.

Exclusion Criteria

1. Previous thromboembolism;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ive birth rate.

Secondary Outcome Measures

Name	Time	Method
1. Prevalence of adverse pregnancy outcomes:<br><br />a. Preeclampsia;<br><br />b. HELLP;<br><br />c. Intrauterine growth retardation;<br><br />d. Premature delivery;<br><br />e. Congenital malformations<br>prevalence of thromboembolic and hemorragic complications;<br><br />f. Thrombocytopenia;<br><br />g. Allergic reactions.